Hamed Movahed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hamed Movahed has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Ehsan Taherifard
Hematology Research Center Shiraz University of Medical Sciences Shiraz Iran
4 shared publications - Erfan Taherifard
Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, CT, USA
4 shared publications - Alireza Ahmadkhani
Department of Pathology Shiraz University of Medical Sciences Shiraz Iran
2 shared publications - Alireza Sadeghi
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications Gordon Guyatt
2 shared publications- Niloofar Dehdari Ebrahimi
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 199
Use of thresholds for rating certainty of evidence with the GRADE framework: a systematic survey of systematic reviews
- 11 August 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 199
Open AccessUse of thresholds for rating certainty of evidence with the GRADE framework: a systematic survey of systematic reviews
- Open Access
- 30 August 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 187, 111962
Trustworthiness of treatment clinical practice guidelines has modestly improved since the introduction of Institute of Medicine standards: a systematic survey
- 30 August 2025
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 187, 111962
Open AccessTrustworthiness of treatment clinical practice guidelines has modestly improved since the introduction of Institute of Medicine standards: a systematic survey
- Open Access
- 23 June 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (6) , e2212
Electrocardiographic findings in patients with sickle cell disease: A protocol for systematic review and meta‐analysis
Background: Despite advancements in the management of patients with sickle cell disease (SCD), the involvement of the cardiovascular system in these patients remains a significant concern. Cardiovascular manifestations of SCD are well‐documented, with electrocardiography (ECG) serving as a valuable diagnostic tool. Studies have reported a high rate of critical ECG findings in patients with SCD that warrants consideration when managing these patients, indicating the need for proactive cardiac screening and management strategies in this patient population. This study aims to systematically review the literature to identify sociodemographic, clinical, and paraclinical factors associated with ECG abnormalities in patients with SCD.Methods: A comprehensive search strategy will be employed across multiple online databases, including PubMed, Embase, Scopus, Web of Science, and Google Scholar, for published and gray literature. Eligible studies will include original articles reporting associations between sociodemographic, clinical, and paraclinical variables and a spectrum of ECG findings in patients with SCD. Independent reviewers will conduct the screening, quality assessment, and data extraction. Quantitative analyses will be performed under a random‐effect model using Comprehensive Meta‐Analysis software, with subgroup analyses based on SCD status, sickle hemoglobinopathy form, and age group.
- 23 June 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (6) , e2212
Open AccessElectrocardiographic findings in patients with sickle cell disease: A protocol for systematic review and meta‐analysis
Background: Despite advancements in the management of patients with sickle cell disease (SCD), the involvement of the cardiovascular system in these patients remains a significant concern. Cardiovascular manifestations of SCD are well‐documented, with electrocardiography (ECG) serving as a valuable diagnostic tool. Studies have reported a high rate of critical ECG findings in patients with SCD that warrants consideration when managing these patients, indicating the need for proactive cardiac screening and management strategies in this patient population. This study aims to systematically review the literature to identify sociodemographic, clinical, and paraclinical factors associated with ECG abnormalities in patients with SCD.Methods: A comprehensive search strategy will be employed across multiple online databases, including PubMed, Embase, Scopus, Web of Science, and Google Scholar, for published and gray literature. Eligible studies will include original articles reporting associations between sociodemographic, clinical, and paraclinical variables and a spectrum of ECG findings in patients with SCD. Independent reviewers will conduct the screening, quality assessment, and data extraction. Quantitative analyses will be performed under a random‐effect model using Comprehensive Meta‐Analysis software, with subgroup analyses based on SCD status, sickle hemoglobinopathy form, and age group.
- 13 February 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (5) , e30916
Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
Background: Previous studies have documented that electrocardiography (ECG) can reveal a range of abnormalities, offering valuable insights into the cardiac evaluation of patients with sickle cell disease (SCD). The objective of this study is to assess the patterns of ECG abnormalities observed in these patients with SCD, and to determine their prevalence.Method: We systematically reviewed the literature using online databases of PubMed, Scopus, Web of Science, Embase, and Google Scholar to identify original studies that reported findings of standard ECG assessments in patients with SCD. Statistical analyses were performed using the random effects model. Additional analyses including sensitivity analysis and subgroup analysis were also conducted.Results: Analysis of data from 59 studies involving 897,920 individuals with SCD revealed that 75% of these patients had abnormal ECG findings (67%–81%), which were predominantly nonspecific ST–T changes, left ventricular hypertrophy, T‐wave changes, prolonged corrected QT (QTc) interval, and ischemic changes. Besides, it was shown that these patients had significantly higher odds of having any ECG abnormalities (OR of 17.50, 4.68–65.49), right atrial enlargement (6.09, 1.48–25.09), left ventricular hypertrophy (3.45, 1.73–6.89), right ventricular hypertrophy (7.18, 2.28–22.57), biventricular hypertrophy (10.11, 1.99–51.38), prolonged QTc interval (5.54, 2.44–12.59), ST depression (3.34, 1.87–5.97), and T‐wave changes (5.41, 1.43–20.56). Moreover, the mean of QTc interval was significantly higher among those with SCD (23.51 milliseconds, 16.08–30.94).Conclusion: Our meta‐analysis showed a higher prevalence of abnormal ECG findings among individuals with SCD. A significant proportion of these patients had various ECG abnormalities, suggesting a potential need for regular ECG assessments for patients with SCD.
- 13 February 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (5) , e30916
Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
Background: Previous studies have documented that electrocardiography (ECG) can reveal a range of abnormalities, offering valuable insights into the cardiac evaluation of patients with sickle cell disease (SCD). The objective of this study is to assess the patterns of ECG abnormalities observed in these patients with SCD, and to determine their prevalence.Method: We systematically reviewed the literature using online databases of PubMed, Scopus, Web of Science, Embase, and Google Scholar to identify original studies that reported findings of standard ECG assessments in patients with SCD. Statistical analyses were performed using the random effects model. Additional analyses including sensitivity analysis and subgroup analysis were also conducted.Results: Analysis of data from 59 studies involving 897,920 individuals with SCD revealed that 75% of these patients had abnormal ECG findings (67%–81%), which were predominantly nonspecific ST–T changes, left ventricular hypertrophy, T‐wave changes, prolonged corrected QT (QTc) interval, and ischemic changes. Besides, it was shown that these patients had significantly higher odds of having any ECG abnormalities (OR of 17.50, 4.68–65.49), right atrial enlargement (6.09, 1.48–25.09), left ventricular hypertrophy (3.45, 1.73–6.89), right ventricular hypertrophy (7.18, 2.28–22.57), biventricular hypertrophy (10.11, 1.99–51.38), prolonged QTc interval (5.54, 2.44–12.59), ST depression (3.34, 1.87–5.97), and T‐wave changes (5.41, 1.43–20.56). Moreover, the mean of QTc interval was significantly higher among those with SCD (23.51 milliseconds, 16.08–30.94).Conclusion: Our meta‐analysis showed a higher prevalence of abnormal ECG findings among individuals with SCD. A significant proportion of these patients had various ECG abnormalities, suggesting a potential need for regular ECG assessments for patients with SCD.
- 6 May 2022
- Published by Taylor & Francis in Infectious Diseases
- Vol. 54 (8) , 543-557
Cytomegalovirus coinfection in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review of reported cases
Dysfunction of both the innate and the adaptive immune systems is observed in severe coronavirus disease 2019 which, together with administration of immunosuppressive drugs, could lead to cytomegal...
- 6 May 2022
- Published by Taylor & Francis in Infectious Diseases
- Vol. 54 (8) , 543-557
Cytomegalovirus coinfection in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review of reported cases
Dysfunction of both the innate and the adaptive immune systems is observed in severe coronavirus disease 2019 which, together with administration of immunosuppressive drugs, could lead to cytomegal...
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Hematology
- Vol. 26 (1) , 225-239
Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases
As COVID-19 is a new emerging disease, the hematological/immunological changes that develop in the infected patients remain unknown. This study aims to systematically review the hematologic autoimm...
- 1 January 2021
- Published by Taylor & Francis in Hematology
- Vol. 26 (1) , 225-239
Open AccessHematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases
As COVID-19 is a new emerging disease, the hematological/immunological changes that develop in the infected patients remain unknown. This study aims to systematically review the hematologic autoimm...